Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder
Clinical trial NCT06414889 · RECRUITING
Trial details
- NCT number
- NCT06414889
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-20
- Primary completion
- 2027-06-30
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.